Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Raw Materials: 2013-2025

Historic Raw Materials for Phibro Animal Health (PAHC) over the last 12 years, with Sep 2025 value amounting to $166.4 million.

  • Phibro Animal Health's Raw Materials rose 116.71% to $166.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.4 million, marking a year-over-year increase of 116.71%. This contributed to the annual value of $162.6 million for FY2025, which is 123.39% up from last year.
  • Per Phibro Animal Health's latest filing, its Raw Materials stood at $166.4 million for Q3 2025, which was up 2.33% from $162.6 million recorded in Q2 2025.
  • Phibro Animal Health's Raw Materials' 5-year high stood at $166.4 million during Q3 2025, with a 5-year trough of $59.8 million in Q2 2021.
  • For the 3-year period, Phibro Animal Health's Raw Materials averaged around $107.6 million, with its median value being $84.4 million (2023).
  • In the last 5 years, Phibro Animal Health's Raw Materials fell by 20.21% in 2023 and then soared by 123.39% in 2025.
  • Phibro Animal Health's Raw Materials (Quarterly) stood at $71.3 million in 2021, then surged by 35.44% to $96.6 million in 2022, then fell by 20.21% to $77.0 million in 2023, then spiked by 89.35% to $145.9 million in 2024, then skyrocketed by 116.71% to $166.4 million in 2025.
  • Its last three reported values are $166.4 million in Q3 2025, $162.6 million for Q2 2025, and $150.8 million during Q1 2025.